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Abstract
The Child Behavior Checklist (CBCL) has been proposed for screening of autism spectrum 
disorders (ASD) in clinical settings. Given the already widespread use of the CBCL, this could 
have great implications for clinical practice. This study examined the utility of CBCL profiles in 
differentiating children with ASD from children with other clinical disorders. Participants were 
226 children with ASD and 163 children with attention-deficit/hyperactivity disorder, intellectual 
disability, language disorders, or emotional disorders, aged 2–13 years. Diagnosis was based on 
comprehensive clinical evaluation including well-validated diagnostic instruments for ASD and 
cognitive testing. Discriminative validity of CBCL profiles proposed for ASD screening was 
examined with area under the curve (AUC) scores, sensitivity, and specificity. The CBCL profiles 
showed low discriminative accuracy for ASD (AUC 0.59–0.70). Meeting cutoffs proposed for 
ASD was associated with general emotional/behavioral problems (EBP; mood problems/
aggressive behavior), both in children with and without ASD. Cutoff adjustment depending on 
EBP-level was associated with improved discriminative accuracy for school-age children. 
However, the rate of false positives remained high in children with clinical levels of EBP. The 
results indicate that use of the CBCL profiles for ASD-specific screening would likely result in a 
large number of misclassifications. Although taking EBP-level into account was associated with 
improved discriminative accuracy for ASD, acceptable specificity could only be achieved for 
school-age children with below clinical levels of EBP. Further research should explore the 
potential of using the EBP adjustment strategy to improve the screening efficiency of other more 
ASD-specific instruments.
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 Introduction
Diagnosis of ASD is often difficult due to the heterogeneity in severity and constellations of 
ASD symptoms, variation in symptom presentation with developmental level and age, and 
common co-occurrence of other psychiatric conditions. Differential diagnosis is further 
complicated by the fact that social difficulties and repetitive behaviors are also seen in 
children with non-ASD diagnoses such as attention-deficit/hyperactivity disorder (ADHD), 
language disorders, intellectual disability (ID), and emotional disorders. Although well-
validated diagnostic instruments are available to aid in differential diagnosis, in-depth 
assessment of ASD is time intensive and requires clinicians with extensive training and 
experience with ASD [Huerta & Lord, 2012]. This has resulted in an increasing effort to 
establish reliable, valid, and cost-efficient instruments that can support clinicians in 
determining a need for further ASD evaluation.
The Child Behavior Checklist (CBCL) is a well established and widely used parent-
completed measure of emotional, behavioral, and social problems in children aged 1.5–5 
years and 6–18 years [Achenbach & Rescorla, 2000, 2001]. It was developed to assess a 
range of problem behaviors rather than ASD in particular, and discriminates well between 
clinic-referred and non-referred children [Achenbach & Rescorla, 2000, 2001]. Recently, the 
instrument developer proposed that the CBCL is also useful for ASD-specific screening 
within clinical settings [Achenbach & Rescorla, 2013].
Multiple CBCL scales and profiles have been suggested for ASD screening. The CBCL/1.5–
5 Withdrawn and Pervasive Developmental Problems (PDP) scales have been reported to 
have high accuracy in distinguishing pre-schoolers with ASD from preschoolers with other 
disorders (AUC 0.85–0.94) [Muratori et al., 2011; Narzisi et al., 2013]. The CBCL/6–18 
scales Withdrawn/Depressed, Social problems, and Thought problems have also been found 
to differentiate well between school-age children with ASD and non-ASD disorders 
[Biederman et al., 2010; Duarte, Bordin, de Oliveira, & Bird, 2003; Ooi, Rescorla, Ang, 
Woo, & Fung, 2011]. However, generalizability of these findings is potentially limited by 
methodological issues, such as exclusion of children with relevant differential diagnoses 
(e.g., ADHD, language/cognitive impairments). Additionally, validity of the results may be 
limited by sampling children with ASD with a high degree of general behavior problems, 
especially when comparison is made with a non-ASD group with lower levels of behavior 
problems. Other studies suggest that emotional/behavior problems (EBP), such as aggressive 
behavior and mood problems, contribute substantially to elevated scores on other ASD 
screening tools [Charman et al., 2007; Hus, Bishop, Gotham, Huerta, & Lord, 2013]. Hus et 
al. [2013] suggested that taking non-ASD-specific behavior problems into account may be 
needed to appropriately interpret scores on ASD screeners.
Some studies have found lower accuracy of CBCL profiles in identifying children with ASD 
in the context of children with other clinical problems (AUC 0.67–0.75) [Myers, Gross, & 
McReynolds, 2014; Ooi et al., 2014; Rescorla, Kim, & Oh, 2014; So et al., 2013]. 
Comparison of results across studies is difficult due to variation in ascertainment methods 
and limited sample characterization in terms of autism symptom severity, intellectual ability, 
and language level. To our knowledge, no previous studies on this topic have completed in-
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depth assessment of ASD for children included in both the ASD group and the comparison 
group. Additionally, there is little information about the effect of including children with 
previous ASD diagnoses, or about child characteristics found to influence other ASD 
screening tools, such as intellectual ability, age, and gender [Charman et al., 2007; 
Cholemkery, Mojica, Rohrmann, Gensthaler, & Freitag, 2014; Corsello et al., 2007].
The variability in discriminative accuracy across studies clearly warrant further examination 
of the CBCL’s validity in distinguishing children with ASD from children with other clinical 
disorders. Screening misclassification may lead to inappropriate clinical decisions in the 
assessment process and/or loss of valuable time for appropriate interventions [Norris & 
Lecavalier, 2010]. This study examines the utility of CBCL scales proposed for ASD-
specific screening to distinguish children with ASD from children with non-ASD disorders 
commonly seen in ASD diagnostic clinics. The study also explores factors that may help 
explain the variability in results.
 Methods
 Participants
The sample consisted of 407 children aged 2–13 years who had been assessed for ASD as 
part of a research study of autism symptoms in children with non-ASD diagnoses of ADHD, 
ID, language disorders, or emotional disorders. For the current study, the only exclusionary 
criteria were incomplete CBCL data (>8 missing items, n = 8), and having no DSM-IV-TR 
disorder (n = 10). The participants were recruited mainly through clinic intake/referral and 
flyers/website communication, either in the Division of Developmental and Behavioral 
Pediatrics at Cincinnati Children’s Hospital Medical Center (CCHMC), or at the University 
of Michigan Autism and Communications Disorders Center (UMACC).
The majority of the parents had some college (n = 143) or a higher education level (n = 166), 
and fewer had H.S. diploma without college (n = 37) or less (n = 10, missing n = 33). No 
significant difference was found between sites in parent education level, X2 = 2.87, df = 3, P 
= 0.41. The proportion of children of non-white/Caucasian ethnicity was higher at CCHMC 
(n = 66, missing n = 1) compared to at UMACC (n = 58, missing n = 1), X2 = 9.68, df = 1, P 
<0.01.
The majority of the children without ASD came from CCHMC (88%). Given that these 
children had previously received non-ASD diagnoses and were not referred for ASD 
concern, they are likely representative of children presenting to general developmental 
disabilities/psychiatric clinics for assessment. The proportions of individual non-ASD 
diagnoses are presented in Table 1. The children with ASD (DSM-IV-TR: autistic disorder, n 
= 156, pervasive developmental disorder-not otherwise specified, n = 65, Asperger 
syndrome, n = 5) came mainly from UMACC (80%). Nearly half received the ASD 
diagnosis for the first time through the research study (preschoolers: 50%, school-aged: 
43%).
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 Measures and Procedure
This research was approved by the Institutional Review Board at CCHMC and UMACC. 
Prior to participation, all caregivers signed an informed consent form.
Parents completed the CBCL prior to the diagnostic evaluation, with a mean time lag of 15 
days (SD = 35). The individual CBCL scales are presented in Table 2. All children 
underwent a comprehensive clinical evaluation, including well-validated diagnostic 
instruments for ASD [i.e., the Autism Diagnostic Interview-Revised, ADI-R; Rutter, 
LeCouteur, & Lord, 2003 and the Autism Diagnostic Observation Schedule, ADOS; Lord, 
Rutter, DiLavore, & Risi, 1999; Lord et al., 2012], the Vineland adaptive behavior scales-II 
[Sparrow, Cicchetti, & Balla, 2005], and cognitive testing: the Differential Ability Scales-II 
[Elliott, 1990; n = 330] or the Mullen Scales of Early Learning, [Mullen, 1995; n = 58]. The 
assessment also included measures relevant for establishing non-ASD diagnoses, such as the 
Conners’ Parent Rating Scale-Revised [Conners, Sitarenios, Parker, & Epstein, 1998], the 
Spence Children’s Anxiety Scale [Spence, 1998], and the Multidimensional Anxiety Scale 
for Children [March, Parker, Sullivan, Stallings, & Conners, 1997]. Following completion of 
all measures, clinicians met to discuss their impressions and assign a consensus diagnosis. 
Although the CBCL was available at time of diagnosis, this instrument was not used in 
determining the presence or absence of ASD.
 Data Analysis
Analyses were carried out separately for the CBCL/1.5–5 and the CBCL/6–18, using the 
Statistical Package for Social Sciences (SPSS) version 21. Significance level was set at alpha 
= 0.05 (two-tailed). Characteristics of the ASD and non-ASD groups were compared using 
chi square tests (Fisher’s exact test if cells <5 observations) and t-tests.
First, we examined whether the CBCL scales suggested for ASD screening (i.e., Withdrawn, 
PDP, Withdrawn/depressed, Social problems, and Thought problems) showed diagnostic 
group differences when controlling for other child characteristics. Multivariate Analysis of 
Covariance (MANCOVA) was used to examine diagnostic group differences on (a) 
composite scales, (b) syndrome scales, and (c) DSM-oriented scales, with gender, nonverbal 
IQ, and age as covariates. Raw scores were used in the MANCOVA, as recommended by 
Achenbach and Rescorla [2000, 2001]. Individual ANCOVAs were only analyzed if the 
MANCOVA was significant. Effect sizes are reported as partial eta squared ( ), interpreted 
as small: 0.01–0.05, medium: 0.06–0.13, and large: ≥0.14.
Logistic regression was used to determine whether scale combinations resulted in 
incremental discriminative validity compared with the individual scales. Discriminative 
validity was examined using area under the curve (AUC) scores from nonparametric receiver 
operating curve (ROC) analyses, which is a plot of true positive vs. false positive results. 
Swets [1988] suggested the following benchmarks for interpreting AUC scores: 0.50–0.70 
(low accuracy), 0.70–0.90 (moderate accuracy), and >0.90 (high accuracy). A sample size 
calculation, using the StatsToDo website (https://www.statstodo.com/
SSizSenSpc_Pgm.php), indicated that 50 cases in each group were needed to detect a 
difference between chance-level and moderate discrimination (AUC = 0.50/0.70, α = 0.05, 
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power = 0.80). For the profile demonstrating the highest AUC-score in each age group, we 
calculated sensitivity, specificity, and positive likelihood ratio (LR+). Confidence intervals 
(95%) were calculated based on the Wilson score method [Newcombe, 1998]. T scores were 
used to facilitate comparison with previous studies.
Stratified analyses were performed to examine whether discriminative accuracy was 
associated with level of EBP, ID, and/or previous ASD diagnosis. The CBCL has multiple 
scales intended to capture emotional problems (e.g., Internalizing, Emotionally reactive, 
Anxious/depressed, Anxiety problems, and Affective problems) and behavioral problems 
(e.g., Externalizing, Attention problems, Attention deficit/hyperactivity problems, 
Oppositional/defiant problems). In operationalizing clinically significant level of EBP, 
avoiding overlap with core ASD behaviors was a priority. Therefore, scales with item 
content clearly overlapping with core ASD behaviors were not considered (e.g., Emotionally 
reactive, Internalizing). Few studies have examined concordance between CBCL scales and 
co-occurring emotional/behavioral disorders in children with ASD. An exception is a recent 
study of school-aged children with ASD, finding the highest discriminative validity for the 
Affective problems and Aggressive behavior scales (AUC = 0.90) [Gjevik, Sandstad, 
Andreassen, Myhre, & Sponheim, 2015]. To avoid the multiple comparisons problem, we 
based the choice of the particular emotional and behavioral scale on this finding. Therefore, 
EBP-level was operationalized as high when T score (age- and gender-normed) on 
Aggressive behavior and/or Affective problems was in the clinical range (≥70). For the EBP 
classification to be useful in children with problems specific to the emotional or behavioral 
domain, high EBP was defined as scoring in the clinical range on either of the scales (results 
were very similar when using only one of the scales).
All results should be interpreted in light of their confidence intervals. Charman et al. [2007] 
found a difference in specificity of 0.41 and 0.93 for another ASD screener between 
subgroups with high and low EBP. A sample size calculation indicated that 13 cases in each 
group were needed to have 80% power to detect a difference of this size (α = 0.05; 
StatsToDo).
 Results
 Sample Characteristics
As shown in Table 1, there were large differences in ADOS scores between the ASD and 
non-ASD groups. The ASD group also showed lower intellectual ability, with significant 
differences in verbal IQ in both age samples, and in nonverbal IQ in the preschool sample. 
No significant differences were found for age or gender proportions. Among children with 
non-ASD disorders, the proportion with language disorders was higher in the preschoolers, 
whereas the proportion with ADHD and emotional disorders was higher in the school-age 
children. The prevalence of high EBP was 33% in the total sample, with no significant 
differences between the ASD and non-ASD groups. The two scales comprising EBP-level 
did not significantly correlate with age, nonverbal IQ, or verbal IQ (Pearson’s r ranged from 
−0.09 to 0.09, P ≥0.16).
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 Group Differences on the CBCL
Table 2 presents mean raw CBCL scores and MANCOVA results for the ASD and non-ASD 
groups (mean T scores are provided as supplementary information). Controlling for gender, 
age, and nonverbal IQ, preschoolers with ASD scored significantly higher than preschoolers 
with non-ASD disorders on Withdrawn and PDP (medium effect sizes, ES). The ASD group 
also scored significantly higher on Total problems, Internalizing, Emotionally reactive, 
Aggressive behavior, and Anxiety problems (small ES). In the school-age sample, the ASD 
group scored significantly higher than the non-ASD group only on the scales suggested for 
ASD screening (i.e., Withdrawn/depressed, Social problems, and Thought problems, small-
to-medium ES), controlling for gender, age, and nonverbal IQ.
 Overall Discriminative Validity
As shown in Table 3, overall discriminative validity of the two CBCL/1.5–5 scales proposed 
for ASD screening was in the low range (AUC 0.68–0.69). Logistic regression showed no 
incremental discriminative value of combining the scales. Only Withdrawn made a 
significant unique contribution to discrimination (B = 0.22, P = 0.01), while the 
nonoverlapping items from PDP did not contribute significantly (B = 0.00, P = 0.99), χ2(2) = 
15.02, P <0.01. Due to similar findings, further results are only presented for Withdrawn.
The CBCL/6–18 scales suggested for ASD screening also resulted in AUC-scores in the low 
range (AUC = 0.59–0.67). Logistic regression showed that combining the scales had 
incremental discriminative value compared to the individual scales. Withdrawn/depressed 
and Thought problems made statistically significant unique contributions to discrimination 
(B = 0.06, P <0.01 and B = 0.05, P <0.01, respectively), whereas Social problems did not 
contribute significantly (B = −0.02, P = 0.32), χ2(3) = 29.04, P <0.01. The aggregated scale 
of T scores from Withdrawn/depressed and Thought problems, hereafter referred to as 
Withdrawn-Thought Problems (WTP), yielded an AUC-score of 0.70.
Given the site differences between the ASD and non-ASD groups, we examined the possible 
covariate effect of site (UMACC vs. CCHMC) using ROC regression in Stata version 13. 
Site did not show a significant covariate effect on either the preschool Withdrawn scale (P = 
0.87) or the school-age WTP scale (P = 0.85).
 Sensitivity, Specificity, and Likelihood Ratio
Sensitivity, specificity, and LR+ of the Withdrawn and WTP scales was examined at two 
previously suggested T score cutoffs of ≥65 and ≥62 [Muratori et al., 2011; Narzisi et al., 
2013], using the aggregated mean scale cutoff when combining scales (≥130 and ≥124 for 
WTP) [Biederman et al., 2010]. At the higher cutoff consistent with the CBCL “borderline 
clinical” cut-point, sensitivity and specificity was 63% (95% CI = 53–73) and 65% (95% CI 
= 51–77) for Withdrawn, and 58% (95% CI = 50–68) and 68% (95% CI = 58–76) for WTP, 
respectively. LR+ was 1.8 for both Withdrawn (95% CI = 1.2–2.7) and WTP (95% CI = 1.3–
2.5).
The lower cutoff resulted in moderate sensitivity (74% for Withdrawn, 78% for WTP) and 
low specificity (53% for Withdrawn, 55% for WTP). Change in probability of ASD 
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diagnosis given scores above the lower cutoff was small both for Withdrawn (1.6) and WTP 
(1.7). The cutoff required to identify at least 80% of children with ASD resulted in 
specificity of 39% for Withdrawn (95% CI = 26–51, cutoff 58) and 53% for WTP (95% CI = 
43–63, cutoff 123).
 Factors Associated With Discriminative Validity
Table 4 presents the results of the subgroup analyses for the more sensitive lower cutoff by 
level of EBP, ID, and previously/first diagnosed ASD. Subgroup analysis by gender was 
attempted, but was not possible due to confounding of gender and high EBP within children 
with ASD, with significantly higher proportion of EBP in girls compared to boys in 
preschoolers (53% vs. 29%), χ2(1, N = 104) = 4.20, P = 0.04, and school-age children (55% 
vs. 31%), χ2(1, N = 122) = 5.75, P = 0.02). There was no significant difference in the 
proportions of high EBP between girls and boys with non-ASD disorders in preschoolers 
(14% vs. 23%), Fisher’s exact P = 0.71, or in school-aged children (32% vs. 33%), χ2(1, N = 
106) = 0.01, P = 0.93).
 Level of EBP
Discriminative utility of the Withdrawn and WTP showed substantial variability depending 
on EBP-level. For both scales, discriminative validity was in the moderate range for children 
with low EBP (AUC = 0.70–0.79) and in the low range for children with high EBP (AUC = 
0.62).
With regard to the CBCL/6–18 WTP, scores at or above 124 were associated with a 3.2 
increase in likelihood of ASD among children with low EBP, in contrast to no increase 
among children with high EBP (1.0). Optimal cutoffs (maximized specificity with sensitivity 
≥80%) were widely differing in children with high compared to low EBP-level. In the low 
EBP subgroup, a cutoff of 117 correctly classified 82% (95% CI = 71–89) of children with 
ASD and 62% (95% CI = 50–73) of children with non-ASD disorders. For children with 
high EBP, compared to cutoff 124, a cutoff of 134 resulted in improved specificity from 6% 
(95% CI = 1–13) to 40% (95% CI = 24–58) while maintaining sensitivity at 81% (95% CI = 
67–91) (see Fig. 1).
Although a similar pattern was found for the CBCL/1.5–5 Withdrawn, CIs were wider, 
especially in the small high EBP subgroup (n = 46). In the larger low EBP subgroup (n = 
115), discriminative accuracy was somewhat lower than for the school-age low EBP 
subgroup (AUC 0.70 vs. 0.79). The cutoff required to identify at least 80% of preschoolers 
with ASD in the low EBP subgroup, resulted in only 33% specificity (cutoff 54, sensitivity: 
87%). Thus, it was not possible to achieve acceptable discriminative accuracy by using 
adjusted cutoffs.
 Intellectual Disability
Due to few children with ID in the preschool non-ASD group (n = 5), this analysis was only 
performed for the school-age sample. Although discriminative accuracy of the WTP was in 
the moderate range for children without ID (AUC = 0.73) and in the low range for children 
with ID (AUC = 0.59), the CIs were highly overlapping.
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 Previously Diagnosed ASD
Limiting the preschool ASD group to previously diagnosed vs. children diagnosed for the 
first time, discriminative accuracy of the Withdrawn scale was in the moderate (AUC = 0.74) 
and low range (AUC = 0.64), respectively. Sensitivity of the lower cutoff was within 
acceptable limits (80%) only for preschoolers with previous ASD diagnoses. However, the 
CIs of the estimates overlapped.
WTP differentiated school-age children with and without ASD similarly when the ASD 
group was limited to children previously diagnosed (AUC = 0.70) as to children first 
diagnosed (AUC = 0.71).
 Discussion
Children with ASD scored significantly higher than children with non-ASD disorders on 
CBCL scales proposed for ASD screening (i.e., Withdrawn, PDP, Withdrawn/depressed, 
Social problems, and Thought problems), when controlling for other child characteristics. 
The CBCL/1.5–5 scales Withdrawn and PDP showed similar differentiation, whereas a 
combination of the CBCL/6–18 scales Withdrawn/depressed and Thought problems 
differentiated best. However, the scales showed low discriminative validity when used to 
distinguish between individual children with ASD and non-ASD disorders (AUC 0.59–
0.70). Scores above previously suggested cutoffs were associated with only a small increase 
in probability of ASD diagnosis (all ≤1.8).
There is an inherent tradeoff between maximizing sensitivity and minimizing false positives, 
and priority depends on the purpose of the instrument. Considering that the CBCL has been 
proposed for screening rather than diagnosis, sensitivity may be considered the highest 
priority. The cutoff required to identify at least 80% of children with ASD in this study was 
lower than found in previous studies. Compared to reported sensitivity of 78–90% 
[Biederman et al., 2010; Myers et al., 2014; Narzisi et al., 2013], sensitivity in this study was 
58–63% at the threshold consistent with the CBCL “borderline clinical” problems cutoff 
(≥65 for individual narrow-band scales; average scale score for scale combinations). Limited 
sample characterization in previous studies makes comparison difficult, which is 
problematic given that sample characteristics influence our ability to predict screening 
efficiency in the intended population. Biederman et al. [2010] reported higher sensitivity in 
their ASD sample characterized by a high level of general behavior problems, consistent 
with the subgroup showing the highest sensitivity in this study. In some studies, lack of 
representation of children with milder ASD presentations (i.e., DSM-IV/ICD diagnoses 
other than autistic disorder) is likely to have contributed to higher sensitivity estimates 
[Myers et al., 2014; Ooi et al., 2011].
Utility of the CBCL to identify children in need of further ASD assessment requires 
specificity within acceptable limits with regard to resources needed to resolve false positive 
cases and potential loss of time for appropriate interventions. At the threshold necessary to 
identify at least 80% of children with ASD, specificity was low (39–53%). This is consistent 
with low-to-moderate specificity found for CBCL profiles in two other studies that included 
a range of non-ASD disorders [Myers et al., 2014; So et al., 2013]. The results indicate that 
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the CBCL scales would likely result in a large number of false positives if used to screen for 
ASD in clinical settings. False positive screening could lead to a narrowing of assessment 
focus, possibly at the expense of more appropriate alternatives. Resolving false positive 
cases can cost valuable time and resources and/or delay delivery of appropriate 
interventions. Additionally, unwarranted referrals to ASD specialty clinics could give rise to 
needless emotional distress and economic expenses for families [Sikora, Hall, Hartley, 
Gerrard-Morris, & Cagle, 2008].
In line with previous findings for other ASD screening tools [Charman et al., 2007], 
specificity was especially low in children with high EBP, with 74–92% of children with non-
ASD disorders misclassified when using proposed cutoffs. Although statistical control is not 
available in clinical practice, clinicians may nevertheless need to take into account the level 
of EBP when interpreting ASD screening results. In this study, the age and gender normed 
CBCL scales Affective problems and Aggressive behavior were used to define an easily 
applicable indicator of high EBP (either scale ≥70). The optimal cutoff maximizing 
specificity with high sensitivity (≥80%) differed widely between the subgroups stratified by 
EBP-level. For the WTP, use of EBP-level specific cutoffs resulted in greatly improved 
specificity in children with high EBP, while maintaining sensitivity above 80% in both EBP 
subgroups and with 62% specificity in children with low EBP. Although this strategy led to 
substantially improved discriminative accuracy, the rate of false positives was still high in 
children with high EBP.
Although EBP-level also seemed to moderate the discriminative accuracy of the preschool 
Withdrawn scale (i.e., differing likelihood ratios by EBP-level), it was not possible to 
achieve similar overall improvement of discriminative accuracy with the use of EBP-level-
specific cutoffs. Unlike the school-age WTP scale, the preschool Withdrawn scale showed 
poor discriminative accuracy among children without clinically significant EBP. There may 
be several explanations for the variability in discriminative accuracy between the 
preschoolers and school-aged children with low EBP. First, different scales were used for the 
two age groups with only the school-age WTP including items related to the repetitive 
behavior symptom domain (e.g., “Repeats certain acts over and over,” “Can’t get his/her 
mind off certain thoughts”). The lack of representation of this core ASD symptom domain 
could help explain the poor discriminative accuracy even in the low EBP subgroup. Another 
contributing factor could be the relatively higher proportion of children with language 
disorders in the preschool compared to the school-aged non-ASD group. Withdrawn has 
been found to be the most commonly elevated narrow-band CBCL scale in pre-schoolers 
with language disorders [Maggio et al., 2014]. Third, given that the choice of the particular 
EBP scales was based on research with school-aged children [Gjevik et al., 2015], 
alternative EBP classifications could potentially be more useful for defining adjusted cutoffs 
on ASD screening scales in preschoolers. Finally, because problem behaviors and symptoms 
may be less differentiated in very young children, it is possible that adjusting for EBP-level 
has less utility for improving discriminative accuracy of ASD screeners in preschoolers 
compared to older children. Future studies could examine this with the use of the same ASD 
screener across age groups.
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The results of this study demonstrate the importance of taking moderating factors such as 
EBP-level into account when evaluating the discriminative validity of screening tools for 
ASD. Given that high EBP was associated with increased likelihood of meeting cutoffs on 
the scales proposed for ASD screening, estimates of discriminative accuracy could vary 
according to the distribution of EBP-level in a particular sample [see Janes & Pepe, 2008]. 
Depending on whether the rate of EBP is higher in the ASD or in the non-ASD comparison 
group, overall estimates of discriminative accuracy could be overestimated or 
underestimated, respectively. Although there was no significant difference on the EBP-level 
classifier between the diagnostic groups in this study, the preschoolers with ASD had 
somewhat higher scores on several emotional/behavioral scales including Aggressive 
behavior compared to preschoolers without ASD. Thus, given that higher EBP would be 
expected to be associated with higher likelihood of meeting cutoffs on the Withdrawn scale, 
the poor overall discriminative accuracy in the preschool age group is perhaps even more 
concerning.
This study adds to the literature on this topic in several ways, including (a) use of a well-
characterized sample of children with ASD and children with previous diagnoses of non-
ASD disorders who all completed a comprehensive diagnostic evaluation of ASD; (b) 
exploring factors that may help explain the variability in results across studies; and (c) 
presenting a strategy for taking EBP-level into account to improve the discriminative 
accuracy for ASD. The results must also be interpreted in light of some methodological 
limitations. The sample consisted mainly of children with relatively high intellectual ability, 
and our findings may not generalize to more cognitively impaired children. However, given 
that the CBCL has not been normed for children with ID, the sample may be especially 
relevant to the population for which it is intended. In common with Biederman et al. [2010], 
the sample included children with previous diagnoses, and child behavior rating may differ 
depending on whether parents are aware of the presence of a diagnosis. However, if previous 
diagnosis leads to more parent awareness of behaviors associated with the particular 
diagnosis, this should have contributed to higher discriminative accuracy for ASD rather 
than lower, further supporting our finding of low overall accuracy. Notably, due to small 
subgroups reflected in wide confidence intervals, power was limited and replication with 
larger samples is needed to yield precise estimates. Another limitation is that the screening 
scales and the EBP classification were derived from the same instrument. Finally, given that 
there is little knowledge about which CBCL scales are most accurate in capturing EBP in 
children with and without ASD and at different age levels, future studies should examine 
which scales and cutoffs are most useful for determining EBP-levels.
Due to the widespread use of the CBCL in clinical settings worldwide, reports of its utility 
for ASD-specific screening could have substantial implications for practice. Although the 
CBCL is useful in providing information about a range of behavioral functions and for 
identifying children with behavior problems (first level screening), the results of this study 
suggest that the CBCL scales are not useful for ASD-specific screening. Although 
adjustment for EBP-level improved specificity, it was not possible to achieve acceptable 
levels of sensitivity and specificity due to moderate discriminative validity even within 
subgroups of children with low EBP, without ID, and with previous ASD diagnoses. 
However, the strategy of using the CBCL to define EBP-level and applying EBP-level 
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specific cutoffs could potentially improve the screening efficiency of other tools that are 
more ASD-specific, such as the Social Responsiveness Scale (Constantino & Gruber, 2005) 
or the Social Communication Questionnaire (Rutter, Bailey, & Lord, 2003). It may also be 
possible to improve the discriminative validity of diagnostic instruments for ASD, such as 
the ADI-R and the ADOS, by taking EBP-level into account. Future research is needed to 
examine this.
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Figure 1. 
Sensitivity and specificity (%) of the WTP scale in children with high EBP (n = 80) at cutoff 
124 and 134. Abbreviation: EBP = emotional/behavioral problems.
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Table 4
Area Under the Curve (AUC) Scores, Sensitivity, Specificity and Positive Likelihood Ratio (95% Confidence 
Intervals) of the Withdrawn and WTP Scales in the Total Sample and in Subgroups
CBCL/1.5–5 Withdrawn (T score ≥62) AUC Sensitivity, % Specificity,% Likelihood ratio+
 Stratification (n ASD/n Non-ASD)
 Total sample (104/57) 0.69 (0.61–0.78) 74 (64–82) 53 (39–66) 1.6 (1.2–2.1)
 High EBP-level (34/12) 0.62 (0.43–0.81) 88 (72–96) 8 (0–40) 1.0 (0.8–1.2)
 Low EBP-level (70/45) 0.70 (0.61–0.80) 67 (55–78) 64 (49–78) 1.9 (1.2–2.9)
 Previous ASD diagnosis (52) 0.74 (0.65–0.84) 81 (67–90) 1.7 (1.3–2.3)
 No previous ASD diagnosis (52) 0.64 (0.54–0.75) 67 (53–79) 1.4 (1.0–2.0)
CBCL/6–18 WTP (Aggregated T score ≥124) AUC Sensitivity,% Specificity,% Likelihood ratio+
Stratification (n ASD/n Non-ASD)
 Total sample (122/106) 0.70 (0.63–0.77) 78 (69–85) 55 (45–64) 1.7 (1.4–2.2)
 High EBP-level (45/35) 0.62 (0.49–0.74) 96 (84–99) 6 (1–13) 1.0 (0.9–1.1)
 Low EBP-level (77/71) 0.79 (0.72–0.86) 68 (56–78) 79 (67–87) 3.2 (2.0–5.1)
 No ID (93/85) 0.73 (0.66–0.81) 80 (70–87) 56 (45–67) 1.8 (1.4–2.4)
 ID (29/21) 0.59 (0.42–0.76) 72 (53–87) 48 (26–70) 1.4 (0.9–2.2)
 Previous ASD diagnosis (70) 0.70 (0.62–0.77) 80 (68–88) 1.8 (1.4–2.2)
 No previous ASD diagnosis (52) 0.71 (0.63–0.79) 75 (61–86) 1.7 (1.3–2.2)
Note. CBCL = Child behavior checklist, ASD = autism spectrum disorder, WTP = Withdrawn-Thought Problems, EBP = emotional/behavioral 
problems, ID = intellectual disability.
Autism Res. Author manuscript; available in PMC 2016 July 11.
